Terms: = Gastric cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
81 results:
1. TOB1 modulates neutrophil phenotypes to influence gastric cancer progression and immunotherapy efficacy.
Zhang J; Li Y; Chen J; Huang T; Lin J; Pi Y; Hao H; Wang D; Liang X; Fu S; Yu J
Front Immunol; 2024; 15():1369087. PubMed ID: 38617839
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy is linked to an amended anti-tumorigenic microenvironment in gastric cancer.
Huan X; Zou K; Zhang P; Ding H; Luo C; Xiang C; Xu S; Zhuang Y; Wu C; Wang Y; Wu X; Chen C; Zhang J; Yao X; Liu F; Liu S; Wu Z
Int Immunopharmacol; 2024 Jan; 127():111352. PubMed ID: 38091833
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
[TBL] [Abstract] [Full Text] [Related]
4. Coding RNA expression profile and transcription factor analysis of H.pylori-associated chronic atrophic gastritis.
Wang X; Dong J; Sheng H; Ma X; Baheti L; Xu J
Adv Med Sci; 2023 Sep; 68(2):491-498. PubMed ID: 37945439
[TBL] [Abstract] [Full Text] [Related]
5. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
6. Effect of sevoflurane on CD4+CD25+foxp3+ regulatory T cells in patients with gastric cancer undergoing radical surgery.
Yong F; Wang H; Li C; Liu W; Wang Z; Jia H
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):214-220. PubMed ID: 37715379
[TBL] [Abstract] [Full Text] [Related]
7. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
Xu D; Liu X; Ke S; Guo Y; Zhu C; Cao H
BMC Cancer; 2023 May; 23(1):464. PubMed ID: 37208608
[TBL] [Abstract] [Full Text] [Related]
8. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of tumor-infiltrating CD163
Kinoshita J; Fushida S; Yamaguchi T; Moriyama H; Saito H; Shimada M; Terai S; Okamoto K; Nakamura K; Ninomiya I; Yagi S; Inaki N
BMC Cancer; 2022 Jun; 22(1):608. PubMed ID: 35658848
[TBL] [Abstract] [Full Text] [Related]
10. Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in gastric cancer Patients.
Wang J; Kunzke T; Prade VM; Shen J; Buck A; Feuchtinger A; Haffner I; Luber B; Liu DHW; Langer R; Lordick F; Sun N; Walch A
Clin Cancer Res; 2022 Jul; 28(13):2865-2877. PubMed ID: 35395077
[TBL] [Abstract] [Full Text] [Related]
11. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.
Xing X; Shi J; Jia Y; Dou Y; Li Z; Dong B; Guo T; Cheng X; Li X; Du H; Hu Y; Jia S; Zhang J; Li Z; Ji J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361730
[TBL] [Abstract] [Full Text] [Related]
12. microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer.
Fang W; Shi C; Wang Y; Song J; Zhang L
Bioengineered; 2022 Jan; 13(1):1025-1038. PubMed ID: 34968167
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical expression of foxp3 in gastric carcinoma; its relation to Ki-67 proliferation marker, HER2/neu expression, and other clinicopathological parameters.
Abd-Allah MYY; Abdel-Salam RA; Refat S
J Immunoassay Immunochem; 2022 Mar; 43(2):1959341. PubMed ID: 34806545
[TBL] [Abstract] [Full Text] [Related]
14. GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of gastric cancer.
Jiang S; Zhang Y; Zhang X; Lu B; Sun P; Wu Q; Ding X; Huang J
Front Immunol; 2021; 12():660397. PubMed ID: 34421887
[TBL] [Abstract] [Full Text] [Related]
15. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
[TBL] [Abstract] [Full Text] [Related]
16. A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancer.
Li S; Sun S; Sun H; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Wang W; Li Z; Ma Y; Xue Y; Zhao Y
Int Immunopharmacol; 2021 Jul; 96():107589. PubMed ID: 34162126
[TBL] [Abstract] [Full Text] [Related]
17. Intratumoral foxp3
Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
[TBL] [Abstract] [Full Text] [Related]
18. Sevoflurane represses the migration and invasion of gastric cancer cells by regulating forkhead box protein 3.
Yong F; Wang H; Li C; Jia H
J Int Med Res; 2021 Apr; 49(4):3000605211005936. PubMed ID: 33906525
[TBL] [Abstract] [Full Text] [Related]
19. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
[TBL] [Abstract] [Full Text] [Related]
20. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
[TBL] [Abstract] [Full Text] [Related]
[Next]
